Skip to main content
. 2024 Dec 2;15:1494003. doi: 10.3389/fimmu.2024.1494003

Table 2.

Subgroup analysis for the risk of COPD related to RA.

Subgroups Included studies OR
(95% CI)
Heterogeneity
I2 (%) P value
Gender
Female 5 1.74 (1.59, 1.90) 0.0 0.000
Male 3 1.57 (1.15, 2.14) 69.5 0.004
Serum reactivity
Seropositive RA 3 2.09 (1.69, 2.57) 51.4 0.000
Seronegative RA 3 1.58 (1.21, 2.06) 50.8 0.001
Study type
Cohort study 7 1.77 (1.60, 1.97) 71.8 0.000
Cross-sectional study 3 0.81 (0.28, 2.36) 96.4 0.706
Case-control study 2 1.43 (1.17, 1.75) 20.0 0.028